4/A

PRIMARY DOCUMENT

Company: ELITE PHARMACEUTICALS INC /NV/
Filed: April 28, 2011
Period of Report: October 30, 2009
Accession Number: 0001465825-11-000007

View Document ↗ View on SEC.gov ↗